167 related articles for article (PubMed ID: 17196785)
1. Use and employer costs of a pharmacotherapy smoking-cessation treatment benefit.
Burns ME; Rosenberg MA; Fiore MC
Am J Prev Med; 2007 Feb; 32(2):139-42. PubMed ID: 17196785
[TBL] [Abstract][Full Text] [Related]
2. Employer-sponsored insurance coverage of smoking cessation treatments.
Levy DE
Am J Manag Care; 2006 Sep; 12(9):553-62. PubMed ID: 16961444
[TBL] [Abstract][Full Text] [Related]
3. Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
Ringen K; Anderson N; McAfee T; Zbikowski SM; Fales D
Am J Ind Med; 2002 Nov; 42(5):367-77. PubMed ID: 12382249
[TBL] [Abstract][Full Text] [Related]
4. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
Johnson JT; Neill KK; Davis DA
J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
[TBL] [Abstract][Full Text] [Related]
5. Purchasing health insurance coverage for smoking cessation treatment: employers describe the most influential information in this decision.
Woolf NH; Burns ME; Bosworth TW; Fiore MC
Nicotine Tob Res; 2006 Dec; 8(6):717-25. PubMed ID: 17132519
[TBL] [Abstract][Full Text] [Related]
6. Trends in employer-sponsored health insurance coverage for tobacco-dependence treatments.
McMenamin SB; Halpin HA; Shade SB
Am J Prev Med; 2008 Oct; 35(4):321-6. PubMed ID: 18692982
[TBL] [Abstract][Full Text] [Related]
7. The demand for health insurance coverage for tobacco dependence treatments: support for a benefit mandate and willingness to pay.
Halpin HA; McMenamin SB; Shade SB
Nicotine Tob Res; 2007 Dec; 9(12):1269-76. PubMed ID: 18058345
[TBL] [Abstract][Full Text] [Related]
8. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
Harris BN; West DS; Johnson J; Hong SH; Stowe CD
J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
[TBL] [Abstract][Full Text] [Related]
9. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
Milani RV; Lavie CJ
Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
[TBL] [Abstract][Full Text] [Related]
10. The costs of cancer to a major employer in the United States: a case-control analysis.
Barnett A; Birnbaum H; Cremieux PY; Fendrick AM; Slavin M
Am J Manag Care; 2000 Nov; 6(11):1243-51. PubMed ID: 11185849
[TBL] [Abstract][Full Text] [Related]
11. Corporate smoking cessation on Long Island.
Mulligan P
Health Promot Pract; 2010 Mar; 11(2):182-7. PubMed ID: 18480319
[TBL] [Abstract][Full Text] [Related]
12. Employee responses to health insurance premium increases.
Goldman DP; Leibowitz AA; Robalino DA
Am J Manag Care; 2004 Jan; 10(1):41-7. PubMed ID: 14738186
[TBL] [Abstract][Full Text] [Related]
13. Under-use of tobacco dependence treatment among Wisconsin's fee-for-service Medicaid recipients.
Burns ME; Fiore MC
WMJ; 2001; 100(3):54-8. PubMed ID: 11491035
[TBL] [Abstract][Full Text] [Related]
14. Self-reported health risks linked to health plan cost and age group.
Hill RK; Thompson JW; Shaw JL; Pinidiya SD; Card-Higginson P
Am J Prev Med; 2009 Jun; 36(6):468-74. PubMed ID: 19460654
[TBL] [Abstract][Full Text] [Related]
15. Use of pharmacotherapy while attempting cessation among Italian smokers.
Ferketich AK; Gallus S; Colombo P; Apolone G; Rossi S; Zuccaro P; La Vecchia C
Eur J Cancer Prev; 2009 Feb; 18(1):90-2. PubMed ID: 19077570
[TBL] [Abstract][Full Text] [Related]
16. Influencing Taft-Hartley Funds to provide tobacco cessation benefits.
Weisman SR; Hennrikus D; Choi K; Nunn B; Forster JL; Hunt MK; Skoog R; Luneburg W; Hesse B
Am J Prev Med; 2012 Nov; 43(5 Suppl 3):S237-41. PubMed ID: 23079222
[TBL] [Abstract][Full Text] [Related]
17. Economic costs of benign prostatic hyperplasia in the private sector.
Saigal CS; Joyce G
J Urol; 2005 Apr; 173(4):1309-13. PubMed ID: 15758787
[TBL] [Abstract][Full Text] [Related]
18. Pharmacy benefit spending on oral chemotherapy drugs.
Curtiss FR
J Manag Care Pharm; 2006 Sep; 12(7):570-7. PubMed ID: 16981802
[TBL] [Abstract][Full Text] [Related]
19. The costs of employee smoking. A computer simulation of hospital nurses.
Swank RT; Becker DM; Jackson CA
Arch Intern Med; 1988 Feb; 148(2):445-8. PubMed ID: 3341841
[TBL] [Abstract][Full Text] [Related]
20. Ouch! My employees' drug therapy costs how much?
Jacobs MS
Benefits Q; 2008; 24(4):16-24. PubMed ID: 19048744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
